Page 182 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 182

CHAPTER 9  Biopsy and Sentinel Lymph Node Mapping Principles  161






  VetBooks.ir
























                           •  Fig. 9.3  Excisional  (top)  contrasted  with incisional  (bottom)  biopsy.  The  top  tumor  should  be  small
                           enough that excisional biopsy will not negatively influence other possible treatments. The bottom tumor,
                           however, requires knowledge of the tumor type before excision to ensure appropriate surgical “dose” is
                           used at the time of definitive removal. Note that the biopsy incision is oriented in such a way to make it
                           easiest to include during wide excision and minimize difficulty with closure.


           techniques are convenient, cost effective, and generally safe, they   splenic mass, testicular tumor, etc.). It is more frequently per-
           may suffer from inadequate visualization and limited biopsy sam-  formed than indicated but when used on properly selected cases,
           ple size compared with other techniques. For example, an endo-  it can be both diagnostic and therapeutic as well as cost effective. 
           scopic biopsy result of ulcerative gastritis in a dog with a firm,
           infiltrative mass of the lesser curvature of the stomach does not   Sentinel Lymph Node Mapping and Biopsy
           rule out gastric adenocarcinoma.                      In veterinary medicine, assessment of nodal metastasis has been
                                                                 largely predicated on palpation or imaging of nodal size and archi-
           Laparoscopy and Thoracoscopy                          tecture with cytologic sampling when abnormal. Sentinel lymph
           Evaluation of the abdomen and thorax via minimally invasive   node (SLN) mapping and subsequent biopsy are performed to
           techniques, when performed by an experienced operator, can yield   identify the first lymph node (LN) to which a cancer is likely to
           important information regarding stage of disease and can procure   spread from a primary tumor and to sample that LN for evidence
           tissue for biopsy. In addition, laparoscopic- and thoracoscopic-   of metastasis. If the SLN is free of metastasis, subsequent LNs in
           assisted removal results in smaller incisions and more rapid recov-  the drainage pattern are also likely to be negative. This method
           ery times compared with open procedures. The option to convert   was initially studied in human cutaneous melanoma to detect
           to an open procedure should be available if problems are encoun-  lymphatic drainage patterns before surgery. It is now a widely uti-
           tered that cannot be adequately addressed using minimally invasive   lized staging procedure in many human cancers, but the evidence
           methods. As specialists become more proficient at these techniques,   for its usefulness in staging has been primarily from the applica-
           more and more options are becoming available for tumor removal.   tion of this technique in human breast cancer patients. The SLN
                                                                 has been classically defined as the first node detectable after peri-
           Image-Guided Biopsy                                   tumoral injection of a radioactive marker and subsequent scintig-
           Diagnostic imaging has greatly expanded the ability to stage   raphy. Visual identification in surgery is typically aided by the use
           various neoplasias. The use of positron emission tomography–   of vital dye injection (e.g., methylene blue) in conjunction with
           computed tomography (PET–CT) in veterinary medicine has also   use of a portable gamma probe in the operating room to detect
           led to significant advances in sentinel node mapping, novel staging   the LN with the greatest radioactivity. In one study of 19 dogs
           methods, and the ability to assess response to treatment. In addi-  with cutaneous mast cell tumors,  the SLN was different from the
                                                                                          3
           tion,  the use of  radiographic-,  fluoroscopic-,  ultrasonographic-,   regional anatomic LN in eight (42%) of these dogs. SLN map-
           CT-, and magnetic resonance imaging (MRI)-guided needle   ping and biopsy identified LN metastasis in these eight dogs and
           aspirates or core biopsies can prevent the need for more invasive   clients were offered adjunctive therapy that otherwise would not
           diagnostic procedures. Commonly biopsied tissue includes lung,   have been considered. 3
           kidney, liver, spleen, prostate, and, more recently, brain.   Indirect lymphography is an alternative to scintigraphic SLN
                                                                 mapping. This procedure involves injection of a contrast agent in
           Excisional Biopsy                                     the periphery of the tumor and serial or real-time imaging to fol-
           This method is utilized when the treatment would not be altered   low contrast uptake in the draining lymphatic basin. This method
           by knowledge of tumor type (e.g., “benign” skin tumors, solitary   uses contrast enhancement of nearby LNs and lymphatic channels
   177   178   179   180   181   182   183   184   185   186   187